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ABSTRACT The antioxidant, antinociceptive, and anti-inflammatory activities of the ethanolic extract from leaves of
Combretum duarteanum (EEC) were assessed in rodents through in vitro tests. The antioxidant activity was investigated by
using thiobarbituric acid reactive species (TBARS), hydroxyl radical–scavenging, and scavenging activity of nitric oxide
assays. The antinociceptive activity was investigated by using acetic acid–induced writhing, formalin, and hot-plate tests in
mice. The anti-inflammatory activity was assessed in rats by using the carrageenan-induced hind-paw edema test and
arachidonic acid–induced paw edema test. EEC possesses a strong antioxidant potential according to the TBARS, nitric oxide,
and hydroxyl radical–scavenging assays; it also presented scavenger activity in all in vitro tests. After intraperitoneal
injection, EEC (100, 200, and 400 mg/kg) significantly reduced the number of writhes (38.1%, 90.6%, and 97.8%, respec-
tively) in a writhing test and the number of paw licks during phase 1 (30.5% and 69.5%, higher doses) and phase 2 (38.1%,
90.6%, and 97.8%, all doses) of a formalin test when compared with the control group. Naloxone (1.5 mg/kg, intraperito-
neally) antagonized the antinociceptive action of EEC (400 mg/kg), and this finding suggests participation of the opioid
system. Administration of 200 and 400 mg/kg (intraperitoneally) of EEC exhibited an anti-inflammatory activity in the
carrageenin test, which was based on interference with prostaglandin synthesis. This finding was confirmed by the arachidonic
acid test. Together, these results indicate that properties of EEC might be further explored in the search for newer tools to treat
painful inflammatory conditions, including those related to pro-oxidant states.
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INTRODUCTION
Medicinal plants, those considered to possesstherapeutic properties, have been used since the be-
ginning of human civilization for treating disease. Their use
for the promotion of human health has significantly in-
creased in recent years because of several factors, including
the safety, effectiveness, and improved quality control of the
phytomedicines available on the market today.1–3 Although
in recent years notable progress has been made concerning
the development of natural therapies, there is an urgent need
to discover effective and potent analgesic and anti-inflam-
matory agents.4–6
The plants of the family Combretaceae comprise 20
genera with approximately 600 species. The largest genera
are Combretum, with about 370 species, and Terminalia,
with about 200 species.7,8 Some species of Combretum have
a broad spectrum of biological activities, including anti-
bacterial, antiprotozoal, anticancer, cytotoxic, analgesic,
and anti-inflammatory.7,9–12
C. duarteanum Cambess is a plant from the north and
northeast of Brazil, known by the popular names ‘‘vaqueta’’
and ‘‘caatinga-branca.’’8,13 Its leaves are used for teas, drinks,
and food supplements for the indigenous populations of
northeast Brazil.8,14 Infusions prepared with the aerial parts
(stems and leaves) of C. duarteanum are used in folk medi-
cine for the treatment of pain and as sedative.8,14 However,
we found no relevant literature substantiating the botanical,
chemical, and pharmacologic studies of this species.
Free radicals and related reactive species are involved in
several pathologic and physiologic processes, including
cancer, cell death, inflammation, and pain.15 Many natural
products exert significant redox activities, which are related
to their therapeutic properties or even a possible toxic
effect.16 The evaluation of the redox properties of such
compounds is crucial for understanding the potential
mechanisms of their biological actions and determining
possible toxic or harmful side effects. Considering the lack
of experimental evidence and scientific investigations on the
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possible therapeutic or redox properties of C. duarteanum,
we sought to evaluate the redox properties and possible
antinociceptive and anti-inflammatory effects of the etha-
nolic extract obtained from the leaves of C. duarteanum
(EEC) in rodents.
MATERIAL AND METHODS
Plant material
Leaves of C. duarteanum were collected in the region
around Serra Branca, Paraiba, Brazil, in March 2007. The
plant was identified by Maria de Fa´tima Agra, PhD, from the
Federal University of Paraiba, and a voucher specimen was
deposited at the Lauro Pires Xavier Herbarium (voucher
number 6767).
Preparation of EEC
Leaves of C. duarteanum were dried in an oven at 40C
and subsequently pulverized. The plant material was cold
macerated with ethanol 95% for 72 hours, and the extract
was concentrated by using a rotary evaporator. A dry solid
(40 g) was obtained, corresponding to a yield of 10%.
Chemicals
Sodium nitroprusside, FeSO4, Griess modified reagent,
2-deoxyribose, 2-thio-barbituric acid, 2,20-azobis[2-methyl-
propionamidine]dihydrochloride, trichloroacetic acid, Trolox
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxilic acid),
acetic acid, norhydroguaiaretic acid, and polyoxyethylene-
sorbitan monolate (Tween 80) were purchased from Sigma
Co. Morphine naloxone, and aspirin (acetylsalicylic acid)
were purchased from Unia˜o Quı´mica. All drugs and the
EEC were administered intraperitoneally in volumes of
0.1 mL/10 g (mice) and 0.1 mL/100 g (rats).
Thiobarbituric acid reactive species assay
Thiobarbituric acid reactive species (TBARS) assay was
used to quantify lipid peroxidation,17 and an adapted
TBARS method was used to measure the antioxidant ca-
pacity of EEC by using egg yolk homogenate as a lipid-rich
substrate.16 Briefly, egg yolk was homogenized (1% w/v) in
20 mM phosphate buffer (pH, 7.4), and 1 mL of homoge-
nate was sonicated and then homogenized with 0.1 mL of
EEC at different concentrations. Lipid peroxidation was
induced by addition of 0.1 mL of AAPH solution (0.12 M).
Control was only EEC vehicle (ethanol 0.1%). Reactions
were carried out for 30 minutes at 37C. After cooling,
samples (0.5 mL) were centrifuged with 0.5 mL of tri-
chloroacetic acid (15%) at 1200 g for 10 minutes. An ali-
quot of 0.5 mL from supernatant was mixed with 0.5 mL
TBA (0.67%) and heated at 95C for 30 minutes. After
cooling, sample absorbance was measured by using a
spectrophotometer at 532 nm. The results were expressed as
percentage of TBARS formed by AAPH alone (induced
control).
Hydroxyl radical–scavenging activity
The formation of hydroxyl radical from Fenton reaction
was quantified by using 2-deoxyribose oxidative degrada-
tion.18 The principle of the assay is the quantification of the
2-deoxyribose degradation product, malondialdehyde, by its
condensation with TBA. Briefly, typical reactions were
started by the addition of Fe2+ (FeSO4 6 mM final concen-
tration) to solutions containing 5 mM 2-deoxyribose, 100 mM
H2O2, and 20 mM phosphate buffer (pH, 7.2). To measure
EEC antioxidant activity against hydroxyl radical, different
concentrations of EEC were added to the system before Fe2+
addition. Reactions were carried out for 15 minutes at room
temperature and were stopped by the addition of 4% phos-
phoric acid (v/v) followed by 1% TBA (w/v, in 50 mM
NaOH). Solutions were boiled for 15 minutes at 95C and then
cooled to room temperature. The absorbance was measured at
532 nm, and results were expressed as malondialdehyde
equivalents formed by Fe2+ and H2O2.
Scavenging activity of nitric oxide
Nitric oxide (NO) was generated from spontaneous de-
composition of sodium nitroprusside in 20 mM phosphate
buffer (pH, 7.4). Once generated, NO interacts with oxygen
to produce nitrite ions, which were measured by the Griess
reaction.19 The reaction mixture (1 mL) containing 10 mM
sodium nitroprusside in phosphate buffer and EEC at dif-
ferent concentrations were incubated at 37C for 1 hours. A
0.5-mL aliquot was taken and homogenized with 0.5 mL
Griess reagent. The absorbance of chromophore was mea-
sured at 540 nm. Percentage inhibition of nitric oxide gen-
erated was measured by comparing the absorbance values of
negative controls (only 10 mM sodium nitroprusside and
vehicle) with assay preparations. Results were expressed as
percentage of nitrite formed by sodium nitroprusside alone.
Animals
Male Swiss mice (weight, 27–32 g) and male Wistar
rats (weight, 150–205 g), 2–3 months of age, were used
throughout this study. The animals were randomly housed in
appropriate cages at a mean temperature – standard devia-
tion of 22C– 1C on a 12-hour/12-hour light/dark cycle
(lights on 06:00–18:00) with free access to food (Purina) and
water. Each group had 10 animals each. In the carrageenan-
induced hind-paw edema test, each group consisted of 10
rats each. Experimental protocols and procedures were ap-
proved by the Federal University of Sergipe Animal Care
and Use Committee (CEPA/UFS number 13/09).
Acetic acid–induced writhing
This test was done by using the method described by
Koster et al.20 and Broadbear et al.21 Initially the mice were
divided into 5 groups (n= 10). Subsequently, EEC (100,
200, and 400 mg/kg), vehicle (saline/Tween-80 0.2%; con-
trol group), and morphine (5 mg/kg) were administered in-
traperitoneally 60 minutes before an injection of 0.85%
acetic acid (0.25 mL/animal). Each animal was isolated in
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an individual observation chamber, and 15 minutes after
acetic acid injection the cumulative number of writhing
responses was recorded for 15 minutes.
Formalin test
The formalin test was carried out as described by Hunskaar
and Hole.22 The animals were divided into 6 groups (n= 10)
and treated intraperitoneally with vehicle (control), EEC
(100, 200, and 400 mg/kg), morphine (5 mg/kg), and aspirin
(200 mg/kg). After 60 minutes, 20lL of a 2.5% formalin
solution (0.92% formaldehyde) in a phosphate buffer (pH,
7.2) was injected into the dorsal surface of the left hind paw
using a microsyringe with a 26-gauge needle. The duration of
paw licking was measured at 0–5 minutes (first phase) and
15–30 minutes (second phase) after formalin administration.
Possible antagonism of the EEC antinociceptive effect
by pretreatment with naloxone
Mice were intraperitoneally pretreated (n = 10) with
1.5 mg/kg of naloxone, a nonselective opioid antagonist, 15
minutes before the intraperitoneal administration of vehicle
(control), EEC (400 mg/kg), or morphine (5 mg/kg). Sub-
sequently, the acetic acid–induced writhing test was per-
formed as described above.
Hot-plate test
The hot-plate test was carried out as described by Eddy
and Leimbach.23 In this test, reaction of mice to painful
stimulus was measured. Mice were placed individually on a
metal plate that was heated to 52C– 0.5C and covered
with a glass cylinder (25 cm high, 15 cm in diameter). The
time elapsing to the first pain response (licking of the
forepaws or jumping) was determined by a stopwatch and
then recorded. The experiments were conducted 60 minutes
after the intraperitoneal administration of the EEC (100,
200, and 400 mg/kg). The effect of pretreatment with nal-
oxone (1.5 mg/kg, intraperitoneally) on the antinociception
produced by EEC (400 mg/kg) and morphine (5 mg/kg, in-
traperitoneally) was determined.
Rota-rod test
Initially, the mice able to remain on the Rota-rod apparatus
(AVS) longer than 180 seconds (9 rpm) were selected 24
hours before the test.24 Then, the selected animals were di-
vided into 5 groups (n= 10) and treated intraperitoneally with
vehicle (control), EEC (100, 200, and 400 mg/kg), and diaz-
epam (3 mg/kg). Thirty minutes later, each animal was tested
on the Rota-rod and the time (in seconds) they remained on
the bar for up to 180 seconds was recorded after 60 minutes.
Carrageenan-induced hind-paw edema in rats
Acute hind-paw edema was produced by injecting 0.1 mL
of carrageenan (prepared as 1% suspension in distillate
water) locally into the plantar aponeurosis of the right hind
paw of rats.25 EEC (100, 200, and 400 mg/kg, intraperito-
neally) was administered to different groups (n = 8); the
other groups served as negative and positive controls and
received vehicle (control) and the standard drug, aspirin
(200 mg/kg, intraperitoneally), respectively. EEC and aspi-
rin were administered 1 hour before the injection of carra-
geenan. The rat paw volume up to the ankle joint was
measured by using a plethysmometer (LE 7500, PanLab) at
0 (just before) and 3 hours after the injection of carrageenan.
Increase in the paw edema volume was considered as the
difference between 0 and 3 hours.
Arachidonic acid–induced rat paw edema
Rat paw edema was induced in animal groups (n = 8) by
subplantar injection into the right hind paw of 0.1 mL 0.5%
arachidonic acid dissolved in carbonate buffer (pH, 8.5).
Norhydroguaiaretic acid (NDGA, 100 mg/kg) as reference
and EEC (200 and 400 mg/kg) were administered intraper-
itoneally 60 minutes before arachidonic acid injection.
Edema volume was measured by plethysmography imme-
diately after arachidonic acid injection and at 30-minute
intervals thereafter for 2 hours.26
Statistical analysis
The obtained data were evaluated by 1-way analysis
of variance followed by the Dunnett or Fisher test. All
statistical analyses were done using GraphPad Prism 5.0
(GraphPad Prism Software Inc., San Diego, CA, USA).
In all cases, differences were considered significant if the
P value was less than .05.
The percentage inhibition by an antinociceptive agent
was determined for the acetic acid–induced writhing and
formalin tests by using the following formula: Inhibition
%= 100· (control- experiment)/control.27 Percentage inhi-
bition of edema volume between treated and control groups
was calculated by using the following formula: Inhibition
% = 100 · (Vc -Vt)/Vc, where Vc and Vt represent mean in-
creases in paw volume in the control and the treated groups,
respectively.
RESULTS AND DISCUSSION
Membrane lipids are the most susceptible target of free-
radical attack and propagation in biological systems.28 Ad-
ditionally, free radicals and related reactive species are
strongly involved in several pathologic and physiologic
processes, including cancer, cell death, inflammation, and
pain.15,19 Thus, we assessed the antioxidant potential of
EEC by testing its ability to prevent oxidative damage to
lipids induced by a free-radical source in vitro (AAPH).
Quantification by TBARS demonstrated that EEC exerts a
significant antioxidant effect against peroxyl radicals gen-
erated by AAPH, protecting lipids from oxidation in a dose-
dependent fashion (Fig. 1). Trolox (300 lM), a synthetic
analogue of vitamin E that protects membranes from oxi-
dative damage in vivo, was used as a general antioxidant
standard for comparison. Therefore, it is possible that EEC
interacts more strongly with specific types of lipids. In a
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lipid-rich system, such as in the TBARS assay, lipids with
lesser affinity to EEC or hydrophilic portions of amphipathic
lipids are more susceptible to radical attack, allowing the
initiation of lipoperoxidation chain reaction.16
We next investigated the antioxidant potential of EEC
against 2 different reactive species in vitro. EEC exerted a
significant scavenging effect against NO, but higher con-
centrations reversed this NO-inhibiting effect and led to a
small increase in NO production compared with lower
concentrations (Fig. 2).
On the other hand, EEC had a strong scavenging effect
against hydroxyl radicals generated in vitro in a dose-
dependent fashion (Fig. 3). These results suggest that the
protection against lipoperoxidation chain reactions observed
in TBARS assay is probably due to interaction of EEC
components with hydroxyl radicals, which is a reactive
oxygen species, instead with NO, which is a reactive
nitrogen species. Although EEC demonstrated an NO-
scavenging effect at certain concentrations, some of its
components probably enhance NO production or cancel the
effect of NO scavengers in EEC when present at higher
concentrations. Shifts from antioxidant to pro-oxidant ef-
fects against specific radicals are common in analyses of
complex mixtures such as plant extracts because many
components present different redox properties depending on
their concentrations.16,19,28
FIG. 1. Thio-barbituric acid-reactive substances (TBARS) in vitro.
A lipid-rich system was incubated with a free-radical source (2,20-
azobis(2-amidinopropan) dihydrochloride [AAPH]) and the effect of
different concentrations of ethanolic extract of Combretum duartea-
num (EEC) on the lipoperoxidation was measured by quantifying
TBARS. ‘‘Control’’ refers to incubation medium without AAPH;
other groups contained AAPH alone or in the presence of different
concentrations of EEC. Trolox was used as standard antioxidant.
Bars represent mean – standard error of the mean. *P < .05,
***P< .0001 (1-way analysis of variance followed by Tukey multiple
comparison post hoc test). AAPH, 2,20-azobis(2-amidinopropan) di-
hydrochloride; EEC, ethanolic extract of Combretum duarteanum;
TBARS, thio-barbituric acid-reactive substances.
FIG. 2. Nitric oxide–scavenging assay. Nitric oxide is generated
from spontaneous decomposition of sodium nitroprusside and inter-
acts with oxygen to produce nitrite ions, which are measured by the
Griess reaction. Groups consisted of sodium nitroprusside alone and
nitrite production by sodium nitroprusside in the presence of different
concentrations of ethanolic extract of Combretum duarteanum. Bars
represent mean – standard error of the mean. ***P< .0001; *P< .05.
One-way analysis of variance followed by Tukey multiple compari-
son post hoc test was applied to all data. EEC, ethanolic extract of
Combretum duarteanum; SNP, sodium nitroprusside.
FIG. 3. Hydroxyl radical–scavenging activity was quantified by
using 2-deoxyribose oxidative degradation in vitro, which produces
malondialdehyde by condensation with 2-thiobarbituric acid. ‘‘Sys-
tem’’ is malondialdehyde production from 2-deoxyribose degradation
with FeSO4 and H2O2 alone. Other groups denote malondialdehyde
production by FeSO4 and H2O2 in the presence of different concen-
trations of EEC. Bars represent mean – standard error of the mean.
***P< .0001; *P < .05. One-way analysis of variance followed by
Tukey multiple comparison posthoc test was applied to all data. EEC,
ethanolic extract of Combretum duarteanum.
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In the acetic acid–induced writhing test, the anti-
nociceptive effect represented by writhe reduction, elicited
by 100, 200, and 400 mg/kg of EEC (mean number of
writhes – standard error of the mean, 1.5– 0.6, 4.1– 1.2, and
3.1– 0.9, respectively) in mice was similar to that of 5 mg/kg
morphine (1.3 – 0.5), a standard opioid drug, when groups
were compared with control (12.6– 2.7) (Table 1). Nalox-
one (1.5 mg/kg, intraperitoneally) antagonized the
antinociceptive response of morphine from 1.3 – 0.5 (with
vehicle only) to 10.2– 2.9 (with vehicle plus naloxone)
writhes in the acetic acid-induced writhing test. Similarly,
naloxone antagonized the effect of EEC (400 mg/kg)
(9.7 – 4.7) when compared with control (Table 1).
Our results show that EEC produced a dose-dependent
inhibition of inflammatory pain in mice, as determined by a
significant reduction in acetic acid–induced abdominal
writhing. Acetic acid–induced abdominal constriction is a
standard, simple, and sensitive test for measuring analgesia
induced by both opioids and peripherally acting analge-
sics.22 This test, besides being the most appropriate anti-
nociceptive model for opioids,29,30 is also commonly used
as a model of visceral inflammatory pain.31 In acetic acid–
induced abdominal writhing, pain is elicited by the injection
of an irritant such as acetic acid into the peritoneal cavity,
which produces episodes of characteristic stretching
(writhing) movements, and inhibition of the number of ep-
isodes by analgesics is easily quantifiable.16,32 Central an-
algesic action was suggested by the blocking effect of
naloxone, a specific antagonist of morphinomimetic recep-
tors.33
EEC significantly inhibited the licking response to the
injected paw when 400 mg/kg (duration of licking,
612.8 – 5.9 seconds) was administered intraperitoneally in
mice compared with the control group (42.0– 7.2 seconds)
in the first phase of the formalin test (Table 2). However,
EEC (200 and 400 mg/kg) significantly (P < .001) inhibited
the second phase. As expected, morphine (5 mg/kg) also
reduced the licking time in both phases of this test (2.1 – 0.9
seconds; 4.8– 2.1 seconds), whereas aspirin (200 mg/kg)
reduced it only during the second phase (3.9– 1.6 seconds).
EEC (100 mg/kg) did not produce any significant changes in
either phase of the formalin test.
The advantage of using the formalin model of nociception
is that it can discriminate pain in its central and peripheral
components.34,35 The test consists of 2 different phases
separated in time: The first one is generated in the periphery
through the activation of nociceptive neurons by the direct
action of formalin, and the second occurs through the acti-
vation of the ventral horn neurons at the spinal cord level.
Morphine, a typical narcotic drug, inhibits nociception in
both phases,36 but drugs with peripheral action, such as in-
domethacin and corticosteroids, inhibit only the second
phase. Moreover, drugs such as acetylsalicylic acid and
paracetamol, which inhibit prostaglandin synthesis, block
only the second phase of the formalin test.22,37
The analgesic action presented by EEC involves su-
praspinal as well as spinal components, as demonstrated by
the use of the hot-plate test.38 The results suggest that EEC
(100, 200, and 400 mg/kg, intraperitoneally) has a central
analgesic effect (Table 3), as evidenced by the prolonged
delay in response time when mice were subjected to a no-
ciceptive stimulus during a hot-plate test. This central an-
algesic action was confirmed by the blocking effect of
naloxone.33
In the Rota-rod test, EEC-treated mice showed no
significant motor performance alterations with doses of
100, 200, or 400 mg/kg (data not shown). As might be ex-
pected, the central nervous system depressant diazepam
(3 mg/kg, intraperitoneally), the standard drug, reduced the
time of treated animals on the Rota-rod after 60 minutes
(41.5 – 10.5 seconds) compared with the control group.
The mean increase in paw edema volume was about
0.89– 0.15 mL in the vehicle-treated control rats. EEC
Table 1. Effect of Ethanolic Extract of Combretum
duarteanum, Morphine, and Naloxone
on Writhing Induced by Acetic Acid
Treatment Dose (mg/kg) Writhings (n)a Inhibition (%)
Vehicle – 12.6 – 2.7 –
EEC 100 1.5 – 0.6b 88.1c
EEC 200 4.1 – 1.2b 68.3c
EEC 400 3.1 – 0.9b 75.4c
EEC + naloxone 400+ 1.5 9.7 – 4.7 23.0
Morphine 5 1.3 – 0.5b 89.7c
Morphine + naloxone 5+ 1.5 10.2 – 2.9 19.1
n= 10.
aValues are presented as mean– standard error of the mean.
bP < .001 (1-way analysis of variance and Dunnett test) compared with
control.
cP< .001 (Fisher test) compared with control.
EEC, ethanolic extract of Combretum duarteanum.
Table 2. Effect of Ethanolic Extract of Combretum
duarteanum, Morphine, and Aspirin
on Formalin-Induced Pain
Licking
0–5 min 15–30 min
Treatment
Dose
(mg/kg)
Score of
paina
Inhibition
(%)
Score of
paina
Inhibition
(%)
Vehicle – 42.0 – 7.2 – 54.0 – 11.2 –
EEC 100 45.0 – 6.6 - 7.1 33.4 – 9.1 38.1b
EEC 200 29.2 – 9.8 30.5b 5.1 – 4.4c 90.6d
EEC 400 12.8 – 5.9e 69.5d 1.2 – 0.4c 97.8d
Morphine 5 2.1 – 0.9c 95.0d 4.8 – 2.1c 91.1d
Aspirin 200 35.4 – 9.8 15.7 3.9 – 1.6c 92.8d
n= 10.
aValues are presented as mean– standard error of the mean.
bP < .05 (Fisher test) compared with control.
cP< .001 (1-way analysis of variance and Dunnett test) compared with
control.
dP < .001 (Fisher test) compared with control.
eP< .05 (1-way analysis of variance and Dunnett test) compared with
control.
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(200 and 400 mg/kg, intraperitoneally) significantly (P <
.05) reduced the mean paw edema volume at 3 hours after
carrageenan injection. EEC (200 and 400 mg/kg, intraperi-
toneally) exhibited anti-inflammatory activity with 53.9%
and 56.25 inhibition of paw edema, respectively, as com-
pared with the control group. However, the standard drug,
aspirin (200 mg/kg, intraperitoneally), showed highly
significant (P < .01) anti-inflammatory activity (76.4% in-
hibition) (Table 4).
Various mediators are released by carrageenan in the rat
paw. Thus, although the initial phase may be due to the
release of histamine and serotonin, kinins may play a role in
the middle phase,39 and prostaglandins could be the
most important mediators in the final 3- to 5-hour post-
carrageenan response.26,40 Table 4 shows that EEC more
strongly inhibited paw edema, suggesting that the extract
may have a selective inhibitory effect on the release or ac-
tions of prostaglandin mediators. In addition, the antioxidant
action of EEC observed in the TBARS and NO assays
suggests that this extract may protect against oxidative
damage to membrane polyunsaturated fatty acids, such as
arachidonic acid, which is a very important component in
the response to pain via the cyclooxygenase pathway.41
Moreover, the paw edema induced by arachidonic acid
is a widely used method for distinguishing between
5-lipooxygenase and cyclooxygenase inhibitors.42 Sub-
plantar injection of arachidonic acid produced significant
edema as early as 30 minutes afterward and reached a peak
at 90 minutes (200 and 400 mg/kg).
EEC (200 and 400 mg/kg) reduced edema formation
when administered intraperitoneally, similar to NDGA
(reference drug) (Table 5). The rat paw edema induced by
arachidonic acid is perceptibly reduced by inhibitors of ar-
achidonic acid metabolism and by corticosteroids and is
insensitive to selective cyclooxygenase inhibitors.43 On the
basis of the present results, we may propose that EEC has an
anti-inflammatory action interfering with prostaglandin
synthesis.
CONCLUSION
Our results suggest that the ethanolic extract of C. duar-
teanum (EEC) exhibits an antioxidant action that prevents
lipoperoxidation, probably due to hydroxyl radical–
scavenging activity, and a clear antinociceptive activity in
mice. Its antinociceptive effect probably occurs via central
Table 3. Effect of Ethanolic Extract of Combretum
duarteanum or Morphine on the Hot-Plate Test
in the Absence and Presence of Naloxone in Mice
Dose
Reaction time (licking of hind paws) (s)a
Treatment (mg/kg) Basal 0.5 h 1 h 1.5 h
Vehicle – 7.5 – 2.1 9.8 – 1.8 8.9 – 1.1 7.7 – 1.6
EEC 100 6.8 – 3.7 11.7 – 1.6 15.3 – 1.4b 15.9 – 1.4b
EEC 200 9.1 – 1.9 12.9 – 1.3 17.6 – 1.3b 14.5 – 1.8b
EEC 400 8.5 – 2.7 13.4 – 1.3 16.2 – 2.7b 18.4 – 2.0c
EEC +
naloxone
400+ 1.5 9.2 – 2.5 11.0 – 2.7 12.5 – 2.8 10.2 – 2.1
Morphine 5 8.2 – 3.3 25.5 – 3.6c 27.3 – 4.5d 29.3 – 1.9d
Morphine +
naloxone
5+ 1.5 7.8 – 3.4 9.4 – 2.1 13.4 – 3.3 8.8 – 3.9
n = 10.
aValues are presented as mean– standard error of the mean.
bP< .05 (Fisher test) compared with control.
cP < .001 (1-way analysis of variance and Dunnett test) compared with
control.
dP< .001 (Fisher test) compared with control.
Table 4. Effect of Ethanolic Extract of Combretum
duarteanum or Aspirin on Carrageenan-Induced
Hind-Paw Edema in Rats
Treatment
Dose
(mg/kg)
Carrageenan-induced
hind-paw edema
volume (mL)a
Inhibition
(%)
Vehicle – 0.89 – 0.15 –
EEC 100 0.73 – 0.17 18.0
EEC 200 0.41 – 0.12b 53.9c
EEC 400 0.39 – 0.09b 56.2c
Aspirin 200 0.21 – 0.05d 76.4c
n = 8.
aValues are presented as mean– standard error of the mean.
bP< = .05 (1-way analysis of variance and Dunnett test) compared with
control.
cP < .001 (Fisher test) compared with control.
dP< .01 (1-way analysis of variance and Dunnett test) compared with
control.
Table 5. Effect of Ethanolic Extract of Combretum
duarteanum on Arachidonic Acid–Induced Rat Paw Edema
Arachidonic acid–induced hind-paw
edema volume (mL)a
Time
(min) Control NDGA
EEC,
200 mg/kg
EEC,
400 mg/kg
30 0.31 – 0.04 0.08 – 0.03b 0.26 – 0.09b 0.17 – 0.06b
60 0.51 – 0.05 0.12 – 0.05b 0.29 – 0.11c 0.23 – 0.13b
90 0.53 – 0.04 0.18 – 0.10b 0.32 – 0.07c 0.22 – 0.09b
120 0.56 – 0.06 0.23 – 0.12b 0.45 – 0.16 0.36 – 0.09c
Inhibitiond – 68.1e 30.9f 48.7e
n = 8.
aValues with plus/minus sign are presented as mean– standard error of the
mean.
bP< .01 (1-way analysis of variance and Dunnett test) compared with
control.
cP< .05 (1-way analysis of variance and Dunnett test) compared with control.
dPercentage inhibition of total edema response.
eP < .01 (Fisher test) compared with control.
fP < .05 (Fisher test) compared with control.
NDGA, norhydroguaiaretic acid.
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inhibitory mechanisms (opioid system) and is not due
to changes in motor coordination. The probable anti-
inflammatory activity of the extract may play a role in ac-
tions that interfere with prostaglandin synthesis and also
might involve redox-mediated mechanisms. Further studies
currently in progress will enable us to understand the precise
mechanisms of action.
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